Picture of Enzychem Lifesciences logo

183490 Enzychem Lifesciences Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+14.7%
3m+12.07%
6m+20.04%
1yr+14.25%
Volume Change (%)
10d/3m+26.57%
Price vs... (%)
52w High-13.06%
50d MA+15.79%
200d MA+22.77%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-7.29%
Return on Equity-4.72%
Operating Margin-18.92%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m31,468.7225,818.4322,975.526,637.6376,038.89n/an/a19.63%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Enzychem Lifesciences EPS forecast chart

Profile Summary

ENZYCHEM LIFESCIENCES CORPORATION is a Korea-based Company mainly engaged in the development and manufacture of medical raw materials. The Company provides D-cycloserine, a synthetic product utilizing chiral technology to treat tuberculosis; antibiotics, such as terizidone, cefbuperazone, cefazedone and others; magnetic resonance imaging (MRI) contrast agents such as gadoterate and gadopentate; others for antithrombotic drugs, antiinflammatory analgesic drugs, and drugs for gastric ulcer and hyperlipidemia. The Company also provides functional health food and finished drug products.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
July 20th, 1999
Public Since
September 25th, 2013
No. of Employees
100
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
85,065,562

183490 Share Price Performance

Upcoming Events for 183490

Enzychem Lifesciences Corp Annual Shareholders Meeting

Q1 2024 Enzychem Lifesciences Corp Earnings Release

Q2 2024 Enzychem Lifesciences Corp Earnings Release

Similar to 183490

Picture of AbClon logo

AbClon

kr flag iconKorea Exchange - KOSDAQ

Picture of ADBiotech Co logo

ADBiotech Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Ahn-Gook Pharmaceutical Co logo

Ahn-Gook Pharmaceutical Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Alteogen logo

Alteogen

kr flag iconKorea Exchange - KOSDAQ

Picture of Aminologics Co logo

Aminologics Co

kr flag iconKorea Exchange - KOSDAQ

FAQ